Peaches Biotech
  • Our companies
  • R&D projects
  • Patents
  • Press
  • Contact
  • English
  • Español
Select Page
Peaches Biotech deciphers communication language between immune cells and other tissues

Peaches Biotech deciphers communication language between immune cells and other tissues

Apr 1, 2022

Peaches Biotech publishes in Biomolecules its work on how the immune system communicates with tissues damaged or attacked by viruses or bacteria. This breakthrough opens a way to find new drugs, of biological origin, of great importance in advanced therapies such as...
“Our approach is very mindful of the specificity of each tumor in each patient.”

“Our approach is very mindful of the specificity of each tumor in each patient.”

Mar 25, 2022

The online healthcare newspaper Con Salud has interviewed our research associate, Dr. Senthil Muthuswamy, Director of Translational Research at the Beth Israel Deaconess Hospital Cancer Center in Boston, and published in detail what the platform consists of. opT of...
Interview with Peaches Biotech’s CEO on Negocios TV

Interview with Peaches Biotech’s CEO on Negocios TV

Nov 8, 2021

...
The Madrid SME Peaches Biotech buys the patent against pancreatic cancer from Harvard

The Madrid SME Peaches Biotech buys the patent against pancreatic cancer from Harvard

Nov 8, 2021

Published by: El Economista The drain of brains and ideas is the norm of Spanish science. But there are always exceptions and one of them is represented by Peaches Biotech. This Madrid SME crossed the Atlantic to land at the prestigious Harvard University and bought a...
Peaches Biotech to develop Harvard patent to identify pancreatic tumor cells

Peaches Biotech to develop Harvard patent to identify pancreatic tumor cells

Oct 18, 2021

Published in infosalus.com The Madrid-based company Peaches Biotech announced on Thursday the incorporation into its research project of a worldwide patent from Harvard University that makes it possible to identify and attack pancreatic tumor cells and other solid...
PDX-derived organoids model in vivo drug response and secrete biomarkers

PDX-derived organoids model in vivo drug response and secrete biomarkers

May 12, 2021

Publicado por PubMed 2020 Nov 5;5(21):e135544. doi: 10.1172/jci.insight.135544. PDX-derived organoids model in vivo drug response and secrete biomarkers Ling Huang 1 2, Bruno Bockorny 1 2, Indranil Paul 3, Dipikaa Akshinthala 1 2, Pierre-Oliver Frappart 4, Omar...
« Older Entries
Next Entries »

About Peaches Biotech

The Peaches Biotech Group works to transfer the most relevant advances in health science and technology to citizens, in order to contribute to the development and well-being of society.

Categories

  • Cover
  • Regenerative Medicine
  • Research
  • Team
  • Uncategorized

Search

Find us

Address
Calle Isabel Colbrand, 6 4ª Planta
Madrid, 28050 (SPAIN)

Opening Hours
Monday to Friday: from 9:00 to 18:00 hs.

Mail
Info@peaches.es

  • Twitter
  • Linkedin
Peaches Biotech © 2021 | Privacy Policy | Disclaimer | Cookies policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.